Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease

Nature Medicine

Volumn 8, Issue 11, 2002, Pages 1270-1275

  Hock, Christoph ^a   Konietzko, Uwe ^a   Papassotiropoulos, Andreas ^a   Wollmer, Axel ^a   Streffer, Johannes ^a   Von Rotz, Ruth C ^a   Davey, Gabriela ^a   Moritz, Eva ^a   Nitsch, Roger M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; BRAIN BLOOD VESSEL; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VACCINATION;

AGED; ALZHEIMER VACCINES; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; BASE SEQUENCE; CROSS REACTIONS; DNA PRIMERS; FEMALE; HUMANS; IMMUNE SERA; MALE; MICE; MICE, TRANSGENIC;

ANIMALIA; MUS MUSCULUS;

EID: 0036853548     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm783     Document Type: Article

References (30)

1. Selkoe, D.J. Alzheimer's disease: Genes, proteins, and therapy. Physiol. Rev. 81, 741-766 (2001).
2. Schenk, D., Games, D. & Seubert, P. Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Aβ immunization. J. Mol. Neurosci. 17, 259-267 (2001).
3. Walsh, D.M. et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539 (2002).
4. Chen, G.Q. et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408, 975-979 (2000).
5. Geula, C. et al. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nature Med. 4, 827-831 (1998).
6. Götz, J., Chen, F., van Dorpe, J. & Nitsch, R.M. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science 293, 1491-1495 (2001).
7. Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177 (1999).
8. Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Med. 6, 916-919 (2000).
9. Sigurdsson, E.M., Scholtzova, H., Mehta, P.D., Frangione, B. & Wisniewski, T. Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am. J. Pathol. 159, 439-447 (2001).
10. Morgan, D. et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982-985 (2000).
11. Janus, C. et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-982 (2000).
12. Younkin, S.G. Amyloid β vaccination: Reduced plaques and improved cognition. Nature Med. 7, 18-19 (2001).
13. DeMattos, R.B. et al. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98, 8850-8855 (2001).
14. DeMattos, R.B., Bales, K.R., Cummins, D.J., Paul, S.M. & Holtzman, D.M. Brain to plasma amyloid-β efflux: A measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264-2267 (2002).
15. Solomon, B., Koppel, R., Frankel, D. & Hanan-Aharon, E. Disaggregation of Alzheimer β-amyloid by site-directed mAb. Proc. Natl. Acad. Sci. USA 94, 4109-4112 (1997).
16. Backskai, B.J. et al. Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nature Med. 7, 369-372 (2001).
17. Bishop, G.M., Robinson, S. R., Smith, M.A., Perry, G. & Atwood, C.S. Call for Elan to publish Alzheimer's trial details. Nature 416, 677 (2002).
18. Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
19. Duff, K. et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713 (1996).
20. Holcomb, L. et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Med. 4, 97-100 (1998).
21. van Dorpe, J. et al. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am. J. Pathol. 157, 1283-1298 (2000).
22. Calhoun, M.E. et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. USA 96, 14088-14093 (1999).
23. Hsiao, K.K. et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203-1218 (1995).
24. Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A. & Linington, C. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36, 220-234 (2001).
25. Poduslo, J.F. & Curran, G.L. Amyloid β peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier. Neuroreport 12, 3197-3200 (2001).
26. Hyman, B. T. et al. Autoantibodies to amyloid-β and Alzheimer's disease. Ann. Neurol. 49, 808-810 (2001).
27. Monsonego, A., Maron, R., Zota, V., Selkoe, D.J. & Weiner, H.L. Immune hyporesponsiveness to amyloid β-peptide in amyloid precursor protein transgenic mice: Implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98, 10273-10278 (2001).
28. Check, E. Nerve inflammation halts trial for Alzheimer's drug. Nature 415, 462 (2002).
29. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984).
30. Folstein, M.F., Folstein, S.E. & McHugh, P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198 (1975).